Effects of a Twelve Months ROSUVASTATIN Treatment Plus Additional Care (Drug Intake Adherence and Lifestyle Enhancing Initiatives ) Compared to ROSUVASTATIN Treatment Alone on Long-Term Disease-Related Costs in Patients With an Indication for Statin Treatment According to the Joint European Guidelines
Latest Information Update: 09 Jul 2009
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Hypercholesterolaemia; Lipid metabolism disorders
- Focus Therapeutic Use
- Acronyms ORBITAL
- Sponsors AstraZeneca
- 25 Oct 2006 New trial record.